{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T00:50:34Z","timestamp":1792025434698,"version":"4.4.0"},"reference-count":41,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JASN"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1681\/asn.2017070819","type":"journal-article","created":{"date-parts":[[2017,11,8]],"date-time":"2017-11-08T09:20:09Z","timestamp":1510132809000},"page":"571-578","source":"Crossref","is-referenced-by-count":166,"title":["Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease"],"prefix":"10.1681","volume":"29","author":[{"given":"Kristen L.","family":"Nowak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiying","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berenice","family":"Gitomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godela","family":"Brosnahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente E.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arlene B.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald D.","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore I.","family":"Steinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaleab Z.","family":"Abebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic F.","family":"Rahbari-Oskoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan S.L.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyongtae T.","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Hogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Miskulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Chonchol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2017,11,8]]},"reference":[{"key":"B2-20230120","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease.","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet"},{"key":"B3-20230120","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1046\/j.1523-1755.2003.00185.x","article-title":"Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.","volume":"64","author":"Chapman","year":"2003","journal-title":"Kidney Int"},{"key":"B4-20230120","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1046\/j.1523-1755.2003.00776.x","article-title":"Epidemiological study of kidney survival in autosomal dominant polycystic kidney disease.","volume":"63","author":"Schrier","year":"2003","journal-title":"Kidney Int"},{"key":"B6-20230120","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1001\/jama.291.7.844","article-title":"Predictors of new-onset kidney disease in a community-based population.","volume":"291","author":"Fox","year":"2004","journal-title":"JAMA"},{"key":"B7-20230120","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1111\/j.1523-1755.2004.00582.x","article-title":"Body mass index and the risk of development of end-stage renal disease in a screened cohort.","volume":"65","author":"Iseki","year":"2004","journal-title":"Kidney Int"},{"key":"B8-20230120","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-144-1-200601030-00006","article-title":"Body mass index and risk for end-stage renal disease.","volume":"144","author":"Hsu","year":"2006","journal-title":"Ann Intern Med"},{"key":"B9-20230120","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/sj.ki.5002586","article-title":"Association between obesity and kidney disease: A systematic review and meta-analysis.","volume":"73","author":"Wang","year":"2008","journal-title":"Kidney Int"},{"key":"B10-20230120","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nm.3092","article-title":"Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy.","volume":"19","author":"Rowe","year":"2013","journal-title":"Nat Med"},{"key":"B11-20230120","doi-asserted-by":"crossref","first-page":"e0146654","DOI":"10.1371\/journal.pone.0146654","article-title":"Inhibition of aerobic glycolysis attenuates disease progression in polycystic kidney Disease.","volume":"11","author":"Riwanto","year":"2016","journal-title":"PLoS One"},{"key":"B12-20230120","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1681\/ASN.2015020132","article-title":"Food restriction ameliorates the development of polycystic kidney disease.","volume":"27","author":"Warner","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"B13-20230120","doi-asserted-by":"crossref","first-page":"F726","DOI":"10.1152\/ajprenal.00551.2015","article-title":"A mild reduction of food intake slows disease progression in an orthologous mouse model of polycystic kidney disease.","volume":"310","author":"Kipp","year":"2016","journal-title":"Am J Physiol Renal Physiol"},{"key":"B14-20230120","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1402685","article-title":"Blood pressure in early autosomal dominant polycystic kidney disease.","volume":"371","author":"Schrier","year":"2014","journal-title":"N Engl J Med"},{"key":"B15-20230120","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/ki.2011.411","article-title":"Analysis of baseline parameters in the HALT polycystic kidney disease trials.","volume":"81","author":"Torres","year":"2012","journal-title":"Kidney Int"},{"key":"B16-20230120","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa054341","article-title":"Volume progression in polycystic kidney disease.","volume":"354","author":"Grantham","year":"2006","journal-title":"N Engl J Med"},{"key":"B17-20230120","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/j.1467-789X.2011.00917.x","article-title":"Multiple signal pathways in obesity-associated cancer.","volume":"12","author":"Chen","year":"2011","journal-title":"Obes Rev"},{"key":"B18-20230120","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1158\/1940-6207.CAPR-08-0022","article-title":"Dietary energy balance modulates signaling through the Akt\/mammalian target of rapamycin pathways in multiple epithelial tissues.","volume":"1","author":"Moore","year":"2008","journal-title":"Cancer Prev Res (Phila)"},{"key":"B19-20230120","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.molmed.2007.04.002","article-title":"mTOR Complex1-S6K1 signaling: At the crossroads of obesity, diabetes and cancer.","volume":"13","author":"Dann","year":"2007","journal-title":"Trends Mol Med"},{"key":"B20-20230120","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.beem.2008.08.009","article-title":"Reducing the weight of cancer: Mechanistic targets for breaking the obesity-carcinogenesis link.","volume":"22","author":"Hursting","year":"2008","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B21-20230120","first-page":"214","article-title":"Calorie restriction: Is AMPK a key sensor and effector?","volume":"26","author":"Cant\u00f3","year":"2011","journal-title":"Physiology (Bethesda)"},{"key":"B22-20230120","doi-asserted-by":"crossref","first-page":"R1198","DOI":"10.1152\/ajpregu.00262.2014","article-title":"Overnutrition, mTOR signaling, and cardiovascular diseases.","volume":"307","author":"Jia","year":"2014","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"B23-20230120","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.molmed.2011.06.003","article-title":"mTOR signaling in polycystic kidney disease.","volume":"17","author":"Ibraghimov-Beskrovnaya","year":"2011","journal-title":"Trends Mol Med"},{"key":"B24-20230120","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease.","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"B25-20230120","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1172\/JCI9622","article-title":"Inhibition of cystic fibrosis transmembrane conductance regulator by novel interaction with the metabolic sensor AMP-activated protein kinase.","volume":"105","author":"Hallows","year":"2000","journal-title":"J Clin Invest"},{"key":"B26-20230120","doi-asserted-by":"crossref","first-page":"C94","DOI":"10.1152\/ajpcell.00677.2008","article-title":"AMP-activated protein kinase phosphorylation of the R domain inhibits PKA stimulation of CFTR.","volume":"297","author":"King","year":"2009","journal-title":"Am J Physiol Cell Physiol"},{"key":"B27-20230120","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","article-title":"AMPK phosphorylation of raptor mediates a metabolic checkpoint.","volume":"30","author":"Gwinn","year":"2008","journal-title":"Mol Cell"},{"issue":"Suppl 10","key":"B28-20230120","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1016\/j.transproceed.2008.10.009","article-title":"mTOR-what does it do?","volume":"40","author":"Hall","year":"2008","journal-title":"Transplant Proc"},{"key":"B29-20230120","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1073\/pnas.1011498108","article-title":"Activating AMP-activated protein kinase (AMPK) slows renal cystogenesis.","volume":"108","author":"Takiar","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B30-20230120","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1530\/ERC-11-0213","article-title":"Calorie restriction and rapamycin inhibit MMTV-Wnt-1 mammary tumor growth in a mouse model of postmenopausal obesity.","volume":"19","author":"Nogueira","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"B31-20230120","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/mc.21878","article-title":"The enhancing effects of obesity on mammary tumor growth and Akt\/mTOR pathway activation persist after weight loss and are reversed by RAD001.","volume":"52","author":"De Angel","year":"2013","journal-title":"Mol Carcinog"},{"key":"B32-20230120","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1373\/clinchem.2007.100156","article-title":"The perfect storm: Obesity, adipocyte dysfunction, and metabolic consequences.","volume":"54","author":"de Ferranti","year":"2008","journal-title":"Clin Chem"},{"key":"B33-20230120","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrneph.2015.46","article-title":"The hallmarks of cancer: Relevance to the pathogenesis of polycystic kidney disease.","volume":"11","author":"Seeger-Nukpezah","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"B34-20230120","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1053\/j.ajkd.2005.08.015","article-title":"Association between body mass index and CKD in apparently healthy men.","volume":"46","author":"Gelber","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"B35-20230120","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1053\/j.ajkd.2005.06.007","article-title":"Obesity and prevalent and incident CKD: The Hypertension Detection and Follow-Up Program.","volume":"46","author":"Kramer","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"B36-20230120","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1053\/j.ajkd.2009.07.018","article-title":"Obesity and change in estimated GFR among older adults.","volume":"54","author":"de Boer","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"B37-20230120","doi-asserted-by":"crossref","first-page":"c16","DOI":"10.1159\/000228071","article-title":"Influence of obesity on progression of non-diabetic chronic kidney disease: A retrospective cohort study.","volume":"113","author":"Othman","year":"2009","journal-title":"Nephron Clin Pract"},{"key":"B38-20230120","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1053\/j.jrn.2010.12.001","article-title":"Body mass index and the risk of progression of chronic kidney disease.","volume":"21","author":"Khedr","year":"2011","journal-title":"J Ren Nutr"},{"key":"B39-20230120","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1093\/ndt\/gfr757","article-title":"Body mass index has no effect on rate of progression of chronic kidney disease in non-diabetic subjects.","volume":"27","author":"Brown","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"B40-20230120","doi-asserted-by":"crossref","first-page":"384","DOI":"10.5301\/jn.5000062","article-title":"Body mass index has no effect on rate of progression of chronic kidney disease in subjects with type 2 diabetes mellitus.","volume":"25","author":"Mohsen","year":"2012","journal-title":"J Nephrol"},{"key":"B41-20230120","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2215\/CJN.04310709","article-title":"The HALT polycystic kidney disease trials: Design and implementation.","volume":"5","author":"Chapman","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"B42-20230120","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/sj.ki.5002771","article-title":"Tracking kidney volume in mice with polycystic kidney disease by magnetic resonance imaging.","volume":"73","author":"Wallace","year":"2008","journal-title":"Kidney Int"},{"key":"B44-20230120","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1681\/ASN.2015050583","article-title":"Predicted mutation strength of nontruncating PKD1 mutations aids genotype-phenotype correlations in autosomal dominant polycystic kidney disease.","volume":"27","author":"Heyer","year":"2016","journal-title":"J Am Soc Nephrol"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201802000-00027","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:22:00Z","timestamp":1786130520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201802000-00027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,8]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2017070819","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732096513.793555207","asserted-by":"object"}]},"ISSN":["1046-6673","1533-3450"],"issn-type":[{"value":"1046-6673","type":"print"},{"value":"1533-3450","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,8]]}}}